BioNexus Gene Lab invests RM 1M for equity stake in Ascension Innovation Sdn Bhd

BioNexus Gene Lab Corp

Investment of RM 1 million (~USD 228k) for a significant equity stake in Ascension Innovation Sdn Bhd (AISB).
AISB operates the aiCMS platform integrating predictive analytics and AI tools for healthcare.
Investment executed through wholly-owned subsidiary MRNA Scientific Sdn Bhd on August 23, 2024.
Collaboration aims to integrate BGLC's genomic screening services with AISB's digital health platforms.
Strategic move to expand BGLC's presence in the digital health sector and enhance personalized care.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.